PERSISTENCE OF VIRAL-RNA IN MOUSE BRAINS AFTER RECOVERY FROM ACUTE ALPHAVIRUS ENCEPHALITIS

被引:102
作者
LEVINE, B
GRIFFIN, DE
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA
关键词
D O I
10.1128/JVI.66.11.6429-6435.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Little is known about the relationship between recovery from acute viral encephalitis and the clearance of viral genetic material from the central nervous system. In a mouse model of Sindbis virus encephalitis, we have previously shown that clearance of infectious virus is mediated by antibody-induced restriction of viral gene expression rather than by cytotoxic destruction of virally infected cells. To explore whether Sindbis virus genomes persist in mouse brain after the clearance of infectious virus, we used reverse transcriptase-polymerase chain reaction amplification methods to detect Sindbis virus RNA in brain samples from immunocompetent BALB/c and antibody-treated immunodeficient scid/CB17 mice. RNA sequences from both the nonstructural region (NSP1 gene) and structural regions (E2 gene) of Sindbis virus were detected in the brains of all BALB/c and antibody-treated scid mice examined at 1, 2, and 3 months after infection. Additional BALB/c mouse brains were also positive at 8, 12, and 17 months after infection. To determine whether persistent RNA was capable of resuming unrestricted replication in the absence of the continuous presence of antiviral antibodies, viral titers were measured in the brains of scid mice at 1, 2, 3, and 6 months after antibody treatment. Viral reactivation was seen in scid mice treated with hyperimmune serum or a low dose of monoclonal antibody to the E2 envelope glycoprotein, but not in mice treated with a high dose of monoclonal antibody to E2. Replication of infectious virus isolated from scid mouse brain could be restricted by repeat treatment with immune serum, indicating that viral reactivation is not due to antibody-escape mutations. These results demonstrate that Sindbis virus can persist long term in a nonproductive form in mouse brain and suggest that the humoral immune response plays an important role in preventing viral reactivation.
引用
收藏
页码:6429 / 6435
页数:7
相关论文
共 39 条
  • [1] Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2
  • [2] MINUS-STRAND RNA-SYNTHESIS IN THE SPINAL CORDS OF MICE PERSISTENTLY INFECTED WITH THEILERS VIRUS
    CASH, E
    CHAMORRO, M
    BRAHIC, M
    [J]. JOURNAL OF VIROLOGY, 1988, 62 (05) : 1824 - 1826
  • [3] MUTATED AND HYPERMUTATED GENES OF PERSISTENT MEASLES VIRUSES WHICH CAUSED LETHAL HUMAN-BRAIN DISEASES
    CATTANEO, R
    SCHMID, A
    SPIELHOFER, P
    KAELIN, K
    BACZKO, K
    TERMEULEN, V
    PARDOWITZ, J
    FLANAGAN, S
    RIMA, BK
    UDEM, SA
    BILLETER, MA
    [J]. VIROLOGY, 1989, 173 (02) : 415 - 425
  • [4] BIASED HYPERMUTATION AND OTHER GENETIC CHANGES IN DEFECTIVE MEASLES VIRUSES IN HUMAN-BRAIN INFECTIONS
    CATTANEO, R
    SCHMID, A
    ESCHLE, D
    BACZKO, K
    TERMEULEN, V
    BILLETER, MA
    [J]. CELL, 1988, 55 (02) : 255 - 265
  • [5] PERSISTENCE OF ENTEROVIRAL RNA IN CHRONIC FATIGUE SYNDROME IS ASSOCIATED WITH THE ABNORMAL PRODUCTION OF EQUAL AMOUNTS OF POSITIVE AND NEGATIVE STRANDS OF ENTEROVIRAL RNA
    CUNNINGHAM, L
    BOWLES, NE
    LANE, RJM
    DUBOWITZ, V
    ARCHARD, LC
    [J]. JOURNAL OF GENERAL VIROLOGY, 1990, 71 : 1399 - 1402
  • [6] CURRENT STATUS OF THE TREATMENT OF ARGENTINE HEMORRHAGIC-FEVER
    ENRIA, D
    FRANCO, SG
    AMBROSIO, A
    VALLEJOS, D
    LEVIS, S
    MAIZTEGUI, J
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1986, 175 (2-3) : 173 - 176
  • [7] ANTI-VIRAL ANTIBODY REACTING ON THE PLASMA-MEMBRANE ALTERS MEASLES-VIRUS EXPRESSION INSIDE THE CELL
    FUJINAMI, RS
    OLDSTONE, MBA
    [J]. NATURE, 1979, 279 (5713) : 529 - 530
  • [8] FUJINAMI RS, 1980, J IMMUNOL, V125, P78
  • [9] MOLECULAR-BASIS OF LATENCY IN PATHOGENIC HUMAN VIRUSES
    GARCIABLANCO, MA
    CULLEN, BR
    [J]. SCIENCE, 1991, 254 (5033) : 815 - 820
  • [10] GILLIS S, 1978, J IMMUNOL, V120, P2027